Share this post on:

Ria for potentially inappropriate medication use in older adults: outcomes of a US consensus panel of authorities. Arch Intern Med 2003, 163(22):2716?724. 4. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly individuals: a national consensus panel. CMAJ 1997, 156(3):385?91. five. Naugler CT, Brymer C, Stolee P, Arcese ZA: Development and validation of an enhancing prescribing within the elderly tool. Can J Clin CD30 Inhibitor Synonyms Pharmacol 2000, 7(2):103?07. 6. van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC: Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria population-based cohort study. Br J Clin Pharmacol 2005, 60(two):137?44. 7. Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157(14):1531?536. 8. CD40 Antagonist medchemexpress Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D: STOPP (Screening Tool of Older Person’s Prescriptions) and Start (Screening Tool to Alert physicians to Ideal Therapy). Consensus validation. Int J Clin Pharmacol Ther 2008, 46(two):72?3. 9. Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, Cruz-Jentoft A, Montero B, Lang PO, Michel JP, O’Mahony D: Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and Get started (Screening Tool to Alert physicians to Right Therapy) criteriaBradley et al. BMC Geriatrics 2014, 14:72 biomedcentral/1471-2318/14/Page 9 of10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28. 29. 30.amongst physicians in six European countries. Age Ageing 2009, 38(5):603?06. Klarin I, Wimo A, Fastbom J: The association of inappropriate drug use with hospitalisation and mortality: a population-based study in the really old. Drugs Aging 2005, 22(1):69?two. Hanlon JT, Maher RL, Lindblad CI, Ruby CM, Twersky J, Cohen HJ, Schmader KE: Comparison of solutions for detecting potential adverse drug events in frail elderly inpatients and outpatients. Am J Well being Syst Pharm 2001, 58(17):1622?626. Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ: Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010, 44(6):957?63. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D: Potentially inappropriate medicines defined by STOPP criteria and the threat of adverse drug events in older hospitalized individuals. Arch Intern Med 2011, 171(11):1013?019. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R: Potentially inappropriate medication use amongst elderly home care patients in Europe. JAMA 2005, 293(11):1348?358. Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, Cook DG: What variables predict potentially inappropriate key care prescribing in older men and women? Analysis of UK primary care patient record database. Drugs Aging 2008, 25(8):693?06. Bradley MC, Fahey T, Cahir C, Bennett K, O’Reilly D, Parsons C, Hughes CM: Potentially inappropriate prescribing and cost outcomes for older individuals: a cross-sectional study applying the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012, 68(10):1425?433. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K: Potentially inappropriate prescribing and cost outcomes for older folks: a national population study. Br J Clin Pharmacol 2010, 69(5):543?52. Garc Rodr uez LAPGS: Use of your UK General Practice Research Data.

Share this post on:

Author: Potassium channel